Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

To report the efficacy and safety of postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and oxaliplatin (FOLFOX) in hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI). PATIENTS AND METHODS: In this randomized, open-label, multicenter trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shao-Hua, Mei, Jie, Cheng, Yuan, Li, Qiang, Wang, Qiao-Xuan, Fang, Chong-Kai, Lei, Qiu-Cheng, Huang, Hua-Kun, Cao, Ming-Rong, Luo, Rui, Deng, Jing-Duo, Jiang, Yu-Chuan, Zhao, Rong-Ce, Lu, Liang-He, Zou, Jing-Wen, Deng, Min, Lin, Wen-Ping, Guan, Ren-Guo, Wen, Yu-Hua, Li, Ji-Bin, Zheng, Lie, Guo, Zhi-Xing, Ling, Yi-Hong, Chen, Huan-Wei, Zhong, Chong, Wei, Wei, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082249/
https://www.ncbi.nlm.nih.gov/pubmed/36525610
http://dx.doi.org/10.1200/JCO.22.01142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082249/
https://www.ncbi.nlm.nih.gov/pubmed/36525610
http://dx.doi.org/10.1200/JCO.22.01142

Ejemplares similares